Main > ONCOLOGY (**) > Sarcoma>Soft Tissue Sarcoma>MET*** > Treatment > JP. E. Eribulin Mesylate>>>
JP. E. Eribulin Mesylate>>>'s subsections
(*) EU Approval Date: 2016. 05.06.
(*) USA Approval Date: 2016. 01.29.
>or UnResectable
>Received Prior Anthracycline Treat
>SubTypes>
Company
Halichondrin B Synthetic Analog
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 18
Patent>UpDate: 2016. 07.26.
TradeMark
TradeMark Web-Site
JP. E. Eribulin Mesylate>>>'s products
This section has no products